| By PR Newswire | Article Rating: |
|
| March 6, 2013 07:39 PM EST | Reads: |
190 |
FARMERS BRANCH, Texas, March 6, 2013 /PRNewswire/ -- CCS Medical announced today that is has entered into an agreement with LifeScan, Inc., to provide diabetes testing supplies to patients across the country.
(Logo: http://photos.prnewswire.com/prnh/20130306/FL72774LOGO )
"This agreement means that CCS Medical is a LifeScan Direct Mail Order Supplier with the ability to serve all Medicare beneficiaries and many commercial plan members who use LifeScan products, such as LifeScan's OneTouch® Ultra® meter and test strips," said Dirk Allison, CCS Medical President and Chief Executive Officer.
"This is a tremendous development for CCS Medical that will enhance our leadership role within the industry," said Allison. "We are excited about our renewed partnership with an industry leader such as LifeScan, which serves to further validate our mission of providing high-quality products to our patients at a low price."
About CCS Medical
Established in 1994, CCS Medical is a rapidly growing provider of low-cost, high-quality products and services delivered directly to homes of patients with chronic conditions. The company offers a single source solution for diabetes testing supplies, insulin pumps, catheters, ostomy supplies, advanced wound care dressings, incontinence supplies, and prescription medications. CCS Medical's patient-centered model specializes in convenient home delivery, product education, and insurance processing. CCS Medical is a privately held company and its largest shareholders are funds managed by Highland Capital Management, L.P. More information is available at www.ccsmed.com.
SOURCE CCS Medical
Published March 6, 2013 Reads 190
Copyright © 2013 SYS-CON Media, Inc. — All Rights Reserved.
Syndicated stories and blog feeds, all rights reserved by the author.
More Stories By PR Newswire
Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

